# ARHGEF10L

## Overview
ARHGEF10L is a gene that encodes the Rho guanine nucleotide exchange factor 10-like protein, which is a member of the Rho guanine nucleotide exchange factors (RhoGEFs) family. This protein plays a crucial role in the regulation of Rho GTPases, particularly RhoA, by facilitating the exchange of GDP for GTP, thereby activating these molecular switches. The ARHGEF10L protein is characterized by structural domains such as the Dbl homology (DH) domain, a putative WD40-like domain, and transmembrane helices, which are essential for its function in cellular signaling pathways (Tang2019ARHGEF10L). It is involved in the RhoA-ROCK1 signaling pathway and has been implicated in processes like epithelial-mesenchymal transition (EMT), which are significant in cancer progression (Porras2021Contribution). The gene's expression and mutations have been associated with hepatocellular carcinoma, highlighting its potential as a therapeutic target (Tang2019ARHGEF10L).

## Structure
The ARHGEF10L protein is a member of the Rho guanine nucleotide exchange factors (RhoGEFs) and is involved in the regulation of Rho GTPases, particularly RhoA. The molecular structure of ARHGEF10L includes a Dbl homology (DH) domain, which is characteristic of RhoGEFs and is crucial for its function in promoting the active GTP-bound state of Rho GTPases (Tang2019ARHGEF10L). The protein also contains a putative WD40-like domain and two predicted transmembrane helices, which are typical features of proteins in this family (Tang2019ARHGEF10L). These structural elements suggest a role in facilitating interactions with other proteins and membranes, which is essential for its function in signaling pathways.

The protein is known to be involved in the RhoA-ROCK1 signaling pathway and plays a significant role in processes such as epithelial-mesenchymal transition (EMT), which are critical in cancer progression (Porras2021Contribution; Tang2019ARHGEF10L). However, specific details on the primary, secondary, tertiary, or quaternary structures of ARHGEF10L are not provided in the available literature.

## Function
The ARHGEF10L gene encodes a protein that functions as a Rho guanine nucleotide exchange factor (RhoGEF), which is involved in the regulation of Rho GTPases. These GTPases are critical for various cellular processes, including the regulation of the actin cytoskeleton, cell morphology, and motility in response to extracellular stimuli (Earp2018Variants). ARHGEF10L specifically facilitates the exchange of GDP for GTP on Rho proteins, thereby activating them. This activation is crucial for signal transduction pathways that influence cell morphology and motility (Tang2019ARHGEF10L).

In healthy human cells, ARHGEF10L is active in the cytoplasm, where it interacts with other proteins to modulate cellular dynamics and contribute to normal cellular function. It specifically induces GDP/GTP exchange at RhoA, a member of the Rho family of small GTPases, but not at Rac1 or Cdc42 (Tang2019ARHGEF10L). The stimulation of RhoA by ARHGEF10L leads to a reorganization of the actin cytoskeleton, which may be implicated in cell division (Liepelt2020Differential). Although the specific function of ARHGEF10L in healthy human cells is not fully detailed, its role in activating RhoA suggests its involvement in maintaining cellular structure and facilitating cell movement.

## Clinical Significance
Mutations and alterations in the expression of the ARHGEF10L gene have been implicated in the development of hepatocellular carcinoma, a common type of liver cancer. The gene is associated with the RhoA-ROCK1 signaling pathway and the epithelial-mesenchymal transition (EMT), both of which are critical in cancer progression. Specific single nucleotide polymorphisms (SNPs) in the ARHGEF10L locus, such as rs2244444 and rs12732894, have shown a strong association with liver cancer, suggesting a genetic susceptibility to the disease (Tang2019ARHGEF10L).

Increased expression of ARHGEF10L in hepatocellular carcinoma tissues correlates with enhanced cell proliferation, migration, and activation of the RhoA-ROCK1 signaling pathway. This overexpression promotes EMT, characterized by the upregulation of mesenchymal markers like vimentin, N-cadherin, and Slug, and the downregulation of the epithelial marker E-cadherin, facilitating tumor invasiveness and metastasis (Tang2019ARHGEF10L). Conversely, inhibiting ARHGEF10L expression in experimental models results in reduced tumor growth and increased apoptosis, indicating its role in promoting tumor cell survival and proliferation (Tang2019ARHGEF10L). These findings highlight the clinical significance of ARHGEF10L in liver cancer and its potential as a therapeutic target.

## Interactions
ARHGEF10L is a Rho-specific guanine nucleotide exchange factor that primarily interacts with RhoA, a member of the Rho GTPase family, to promote its active GTP-bound state. This interaction specifically activates RhoA but not RhoB or RhoC, indicating a selective interaction with RhoA (Tang2019ARHGEF10L). The activation of RhoA by ARHGEF10L leads to increased expression of ROCK1, a downstream effector in the RhoA signaling pathway, which is crucial for various cellular processes, including cell proliferation and migration (Tang2019ARHGEF10L).

ARHGEF10L also influences the expression of phospho-Ezrin/Radixin/Moesin (ERM) proteins, which are important for cell adhesion. Overexpression of ARHGEF10L increases phospho-ERM expression, while ROCK1 knockdown reduces it, suggesting a regulatory interaction between ARHGEF10L, RhoA, ROCK1, and ERM proteins (Tang2019ARHGEF10L). These interactions contribute to the epithelial-mesenchymal transition (EMT) in liver cancer cells, as ARHGEF10L overexpression upregulates mesenchymal markers and downregulates epithelial markers, promoting EMT (Tang2019ARHGEF10L). These findings highlight the role of ARHGEF10L in modulating key signaling pathways through its interactions with RhoA and associated proteins.


## References


[1. (Porras2021Contribution) Almudena Porras, Celia Sequera, Paloma Bragado, Alvaro Gutierrez-Uzquiza, and Carmen Guerrero. Contribution of c3g and other gefs to liver cancer development and progression. Hepatoma Research, 2021. URL: http://dx.doi.org/10.20517/2394-5079.2021.16, doi:10.20517/2394-5079.2021.16. This article has 0 citations.](https://doi.org/10.20517/2394-5079.2021.16)

[2. (Liepelt2020Differential) Anke Liepelt, Philipp Hohlstein, Hendrik Gussen, Jia Xue, Anna C. Aschenbrenner, Thomas Ulas, Lukas Buendgens, Klaudia T. Warzecha, Matthias Bartneck, Tom Luedde, Christian Trautwein, Joachim L. Schultze, Alexander Koch, and Frank Tacke. Differential gene expression in circulating cd14+ monocytes indicates the prognosis of critically ill patients with sepsis. Journal of Clinical Medicine, 9(1):127, January 2020. URL: http://dx.doi.org/10.3390/jcm9010127, doi:10.3390/jcm9010127. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jcm9010127)

[3. (Earp2018Variants) Madalene Earp, Jonathan P. Tyrer, Stacey J. Winham, Hui-Yi Lin, Ganna Chornokur, Joe Dennis, Katja K. H. Aben, Hoda Anton‐Culver, Natalia Antonenkova, Elisa V. Bandera, Yukie T. Bean, Matthias W. Beckmann, Line Bjorge, Natalia Bogdanova, Louise A. Brinton, Angela Brooks-Wilson, Fiona Bruinsma, Clareann H. Bunker, Ralf Butzow, Ian G. Campbell, Karen Carty, Jenny Chang-Claude, Linda S. Cook, Daniel W Cramer, Julie M. Cunningham, Cezary Cybulski, Agnieszka Dansonka-Mieszkowska, Evelyn Despierre, Jennifer A. Doherty, Thilo Dörk, Andreas du Bois, Matthias Dürst, Douglas F. Easton, Diana M. Eccles, Robert P. Edwards, Arif B. Ekici, Peter A. Fasching, Brooke L. Fridley, Aleksandra Gentry-Maharaj, Graham G. Giles, Rosalind Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Michelle A. T. Hildebrandt, Peter Hillemanns, Claus K. Hogdall, Estrid Høgdall, Satoyo Hosono, Edwin S. Iversen, Anna Jakubowska, Allan Jensen, Bu-Tian Ji, Audrey Y. Jung, Beth Y. Karlan, Melissa Kellar, Lambertus A. Kiemeney, Boon Kiong Lim, Susanne K. Kjaer, Camilla Krakstad, Jolanta Kupryjanczyk, Diether Lambrechts, Sandrina Lambrechts, Nhu D. Le, Shashi Lele, Jenny Lester, Douglas A. Levine, Zheng Li, Dong Liang, Jolanta Lissowska, Karen Lu, Jan Lubinski, Lene Lundvall, Leon F. A. G. Massuger, Keitaro Matsuo, Valerie McGuire, John R. McLaughlin, Iain McNeish, Usha Menon, Roger L. Milne, Francesmary Modugno, Kirsten B. Moysich, Roberta B. Ness, Heli Nevanlinna, Kunle Odunsi, Sara H. Olson, Irene Orlow, Sandra Orsulic, James Paul, Tanja Pejovic, Liisa M. Pelttari, Jenny B. Permuth, Malcolm C. Pike, Elizabeth M. Poole, Barry Rosen, Mary Anne Rossing, Joseph H. Rothstein, Ingo B. Runnebaum, Iwona K. Rzepecka, Eva Schernhammer, Ira Schwaab, Xiao-Ou Shu, Yurii B. Shvetsov, Nadeem Siddiqui, Weiva Sieh, Honglin Song, Melissa C. Southey, Beata Spiewankiewicz, Lara Sucheston-Campbell, Ingvild L. Tangen, Soo-Hwang Teo, Kathryn L. Terry, Pamela J. Thompson, Lotte Thomsen, Shelley S. Tworoger, Anne M. van Altena, Ignace Vergote, Liv Cecilie Vestrheim Thomsen, Robert A. Vierkant, Christine S. Walsh, Shan Wang-Gohrke, Nicolas Wentzensen, Alice S. Whittemore, Kristine G. Wicklund, Lynne R. Wilkens, Yin-Ling Woo, Anna H. Wu, Xifeng Wu, Yong-Bing Xiang, Hannah Yang, Wei Zheng, Argyrios Ziogas, Alice W Lee, Celeste L. Pearce, Andrew Berchuck, Joellen M. Schildkraut, Susan J. Ramus, Alvaro N. A. Monteiro, Steven A. Narod, Thomas A. Sellers, Simon A. Gayther, Linda E. Kelemen, Georgia Chenevix-Trench, Harvey A. Risch, Paul D. P. Pharoah, Ellen L. Goode, and Catherine M. Phelan. Variants in genes encoding small gtpases and association with epithelial ovarian cancer susceptibility. PLOS ONE, 13(7):e0197561, July 2018. URL: http://dx.doi.org/10.1371/journal.pone.0197561, doi:10.1371/journal.pone.0197561. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0197561)

[4. (Tang2019ARHGEF10L) Junyi Tang, Chunyan Liu, Bing Xu, Dawei Wang, Zhenshen Ma, and Xiaotian Chang. Arhgef10l contributes to liver tumorigenesis through rhoa-rock1 signaling and the epithelial-mesenchymal transition. Experimental Cell Research, 374(1):46–68, January 2019. URL: http://dx.doi.org/10.1016/j.yexcr.2018.11.007, doi:10.1016/j.yexcr.2018.11.007. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2018.11.007)